Vial Labeling (51662 1579 1 Vial Labeling)
Flumazenil Injection, Solution
Product Images NDC 51662-1579
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Flumazenil (NDC 51662-1579). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Cp1 (Cp 1)
Cp2 (Cp 2)
This text appears to describe pharmacokinetic data for a drug or compound. It includes measures such as the volume of distribution (Vd), the area under the concentration-time curve (AUC), the clearance rate (CL), and the half-life of the substance. There are also percentage values and ranges provided for each measure, which may indicate variability or uncertainty in the data.*
Description (Description)
Hs (Hs)
This is information about two products - Flumazenil Injection, USP 0.5mg per 5mL and Flumazenil Injection, USP 1mg per 10mL. The products are available in multiple dose vials and individually packaged vials. The NDC (National Drug Code) numbers for the products are mentioned.*
Logo (Logo)
Serialized Labeling (Serialized Labeling)
Warnings (Warnings)
The use of flumazenil may cause seizures, especially in patients who have been on benzodiazepines for long-term sedation or in overdose cases showing signs of serious cyclic antidepressant overdose. Practitioners should be cautious when administering flumazenil, and be prepared to manage seizures.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
